| 注册
首页|期刊导航|实用肝脏病杂志|药物性肝损伤诊断进展

药物性肝损伤诊断进展

王青青 胡晓娜(综述) 保志军(审校)

实用肝脏病杂志Issue(4):441-444,4.
实用肝脏病杂志Issue(4):441-444,4.DOI:10.3969/j.issn.1672-5069.2014.04.032

药物性肝损伤诊断进展

Progress in the diagnosis of drug-induced liver injury

王青青 1胡晓娜(综述) 1保志军(审校)1

作者信息

  • 1. 200040上海市复旦大学附属华东医院消化内科
  • 折叠

摘要

Abstract

Drug-induced liver injury (DILI) refers to varying degrees of liver damage which caused by the drug itself or its metabolites. In recent years, there has been an increasing number of reports about DILI. However, it is often misdiagnosed for the low incidence of DILI symptoms and lack of specificity. There are various diagnostic criteria of DILI in dif erent countries. So it is of great significance to compare the advantages and disadvantages of these criteria and to find the best diagnostic strategy for early treatment and prognosis of DILI.

关键词

药物性肝损伤/诊断标准/进展

Key words

Drug-induced liver injury/Diagnostic criteria/Progress

引用本文复制引用

王青青,胡晓娜(综述),保志军(审校)..药物性肝损伤诊断进展[J].实用肝脏病杂志,2014,(4):441-444,4.

实用肝脏病杂志

OACSTPCD

1672-5069

访问量0
|
下载量0
段落导航相关论文